SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IPIC
IPIC 0.00010000.0%Aug 15 3:35 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: far east who wrote (717)9/23/1997 9:19:00 AM
From: WeirdPro Randy   of 1359
 
As far east writes," IPIC should go back up gradually to 20-25 before FDA review of the drug. One thing to IPIC's advantage, there is currently no cure for stroke. Citicoline will be the only game in town for a while."
It will be the only game in town......one piece of news that no one discussed last week, was the announcement by Cambridge Neurosciences of their phase III failure for Cerestat for traumatic brain injury, and the only product with potential to rival cicicoline anywhere on the horizon.
The another big plus for citicoline is IPIC will be on this alone, no AHP or other big Pharma to share the revenues..........VERY BIG!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext